Title: Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Xiaofang Bian
Special MTA: None
ATGTCCGGCCGTCGCAAGGGCTGCTCGGCGGCCACGGCGTCTTCCTCCTCGTCGTCGCCG
CCGTCGCGCCTTCCTCCTCTGCCTGGGCACGCGCGTCGGCCGCGTCGCAAACGCTGCTTG
GTACCCGAGGTCTTTTGCACGCGCGACTTGGCCGATCTGTGCGTGCGACGCGACTATGAG
GGCCTGCGGCGTTATTTGCGGCGCTTCGAGGGCTCGTGCGTGTCGCTGGGCTGGCCCTCG
CAGTGCATCTACGTGGTCGGGGGCGAGCATTCGCCGCACTCGCTGACCGAGATCGATCTG
GAGCACTGCCAGAACGACTTTTTCGGCGAATTCCGAGCTCTGCATCTCATTGGCACGGTC
TCGCACGCCACCTGCCGGTACCAGGTGTTCGTGGACGCGTACGGCGCCGTGTTCGCCTAC
GACGCGCAAGAGGACTGCCTGTACGAGTTGGCCTCGGATCTGGCCGGATTTTTTGCCAAG
GGCATGATTCGCTGCGACCCGGTGCACGAATCCATCTGCGCGCGTCTGCAACCCAACGTG
CCCTTGGTGCATCCCGACCATCGGGCCGAGCTGTGCCGCCGCTCGCGCGCCTCCGCTCGC
GGCCGCTATCTACGTTCGCTGCTGGCTTTCCGCGAGTTGCTGGCCTGCGAGGACACCGCC
GCTCGCTGTGCCTACGTAGAGGCGCACCGCGAGGCGCAGCTGACCCTCATCTGGCCTGAG
AAGCATTCCCTGGTGCTGCGCACGGCGCGCGATCTGGGGCTCTCGGCCTCGATGCTGCGC
CGCTTTCAACGTTCGTTGTACACGCGCGAGCCCGTCATGCCGCTGGGCGAGATCGAGGGC
GCTGAGGACAAGACCTTCTTTCACCGCGTGCGGATTCTCTGCGGCGACACGGGCACCGTG
TACGCGGCGCTGGTGGGGCAGGATAAGTTGGTGCGGCTGGCGCGCGACCTCAGGGGCTTC
GTGCGCGTGGGGCTGGCGCTGCTCATCGACGACTTTCGCTACGAGAGCATCGGCCCCGTG
GACCGCAGCTCGCTGTACGAGGCCAATCCCGAGCTGAGACTGCCGTTCAAAAAGCGTAGG
CTCGTCGTGGGCTACTTTGACTCGCTATCGTCGCTCTATCTGCGCGGGCAGCCCAAGTTC
AGCAGCATCTGGCGCGGTCTGCGTGATGCCTGGACCCACAAGCGCCCGAAGCCGCGCGAG
CGTGCGAGCGGGGTTCACCTGCAGCGCTACGTACGCGCCACGGCGGGTCGTTGGCTCCCG
CTGTGCTGGCCGCCGCTGCACGGCATCATGCTGGGCGACACTCAGTACTTTGGGGTGGTG
CGCGATCACAAGACCTACCGGCGCTTCTCGTGCCTGCGCCAGGCTGGCCGCTTGTACTTT
ATCGGCCTCGTCAGTGTGTACGAATGCGTGCCGGACGCAAACACGGCGCCCGAGATCTGG
GTCTCCGGGCACGGGCACGCCTTTGCGTACCTGCCCGGCGAGGACAAGGTGTACGTGCTG
GGGCTCTCGTTTGGCGAGTTTTTTGAGAACGGTCTCTTTGCCGTGTACAGCTTCTTTGAG
CGCGACTACGTGGATGAAATCGTAGAGGGCGCATGGTTTAAGCACACCTTTGCGGGCATG
TACGAACTCTCCCAGATACTGCACGACCGCACCAATCTGCTGCGCGTATGTCAGCTCCAC
GCCGGTAGCAAGATCCGCCTGGGCGGCTCGCCCGCTTGTACTTTCACTTTCGGCTCGTGG
AACGTGGCCGAGGCCGACGAGGCCAACAATTTTGTGATCGGCGTGCTAGAACAGGCCCAC
TTTGTAGTCATCGGATGGATGGAGCCCGTGAACAAAGCCGTATTTATGGACGCGCACGGC
GGCATTCACGTACTGCTGTACGGTACGATGCTGGTTAAGTTGGCCGAGACGCTGCGCGGT
TTTATCCGTCAGGGCTCCTTCTGGTTTCGTTGCCCACGGCGTTTTTGCTTCTCGCCGTTG
GACTCGAGCGCAACCGTCGCCGCGAAACCGGTGAGCAGCCATACATCGCCCGCGTACGAC
GTCAGCGAGTACGTGTTTTCGGGCCGTAGCGTGCTGGATAGCGTGAGCGGCACGGGGGCG
TCG
MSGRRKGCSAATASSSSSSPPSRLPPLPGHARRPRRKRCLVPEVFCTRDLADLCVRRDYE GLRRYLRRFEGSCVSLGWPSQCIYVVGGEHSPHSLTEIDLEHCQNDFFGEFRALHLIGTV SHATCRYQVFVDAYGAVFAYDAQEDCLYELASDLAGFFAKGMIRCDPVHESICARLQPNV PLVHPDHRAELCRRSRASARGRYLRSLLAFRELLACEDTAARCAYVEAHREAQLTLIWPE KHSLVLRTARDLGLSASMLRRFQRSLYTREPVMPLGEIEGAEDKTFFHRVRILCGDTGTV YAALVGQDKLVRLARDLRGFVRVGLALLIDDFRYESIGPVDRSSLYEANPELRLPFKKRR LVVGYFDSLSSLYLRGQPKFSSIWRGLRDAWTHKRPKPRERASGVHLQRYVRATAGRWLP LCWPPLHGIMLGDTQYFGVVRDHKTYRRFSCLRQAGRLYFIGLVSVYECVPDANTAPEIW VSGHGHAFAYLPGEDKVYVLGLSFGEFFENGLFAVYSFFERDYVDEIVEGAWFKHTFAGM YELSQILHDRTNLLRVCQLHAGSKIRLGGSPACTFTFGSWNVAEADEANNFVIGVLEQAH FVVIGWMEPVNKAVFMDAHGGIHVLLYGTMLVKLAETLRGFIRQGSFWFRCPRRFCFSPL DSSATVAAKPVSSHTSPAYDVSEYVFSGRSVLDSVSGTGAS
Coding Sequence Details
Recommended Growth Condition: